TSX open
Loading markets…

Advertisement

Stocks

Why Profound Medical Corp stock went up yesterday

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:PRN.TO

Follow PRN

Photos provided by Pexels

Profound Medical Corp experienced a notable increase in its stock price, reflecting investor confidence in its innovative healthcare solutions.

Profound Medical Corp (PRN.TO) saw its stock rise by 2.94% in yesterday's trading session, closing at CA$8.41. This uptick comes amid growing interest in AI-driven healthcare technologies, particularly those that enhance treatment precision and patient outcomes.

Advertisement

Profound Medical Corp

PRN.TO

Full stock page →

PRN.TO

Profound Medical Corp

Source:WealthAwesomeWealthAwesome
↓ $0.67 (-7.38%)
120 day period
$7.92$9.84$11.76Apr 8Jul 3Sep 28

Market cap

$307.30M

52W high

$12.40

52W low

$6.52

1W change

-1.75%

Beta

0.50

Analyst Price Targets

Based on analyst covering PRN · as of Sep 17, 2026

📈

Wall Street analysts forecast PRN stock price to rise 197.6% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$25.03

+197.6% Upside

Current Price

C$8.41

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on PRN's historical volatility

HistoricalForecast68%95%
C$3.45C$5.63C$7.80C$9.97C$12.15C$14.32TodayMay 21Jul 24Sep 28Nov 10Dec 24Feb 5

30-Day Vol

57.0%

Annualized

90-Day Vol

53.6%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$7.03

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$7.92C$6.51 – C$9.65
60 trading daysC$7.47C$5.65 – C$9.86
90 trading daysC$7.03C$5.00 – C$9.89

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: The rise in Profound Medical's stock price highlights the market's positive reception to advancements in AI healthcare solutions, suggesting potential for future growth as adoption increases.

Profound Medical Corp's stock increased by 2.94%

With a market cap of CA$307 million, Profound Medical is at the forefront of AI healthcare solutions, yet it remains to be seen how quickly hospitals will integrate these technologies into routine practice.

Bull case

The company's innovative MRI-guided robotic systems, like TULSA-PRO, have the potential to change treatment options for prostate and other conditions. As hospitals start to adopt these technologies, Profound Medical could see significant revenue growth.

Bear case

Despite the positive movement, the company faces challenges with hospital adoption rates. Slow integration could limit the scalability of its technologies and impact future earnings.

Market Reaction to AI Innovations

Advertisement

The healthcare sector is increasingly embracing AI technologies, and Profound Medical's advancements in MRI-guided robotic systems reflect this trend. Investors responded positively to the company's recent developments, which promise to enhance treatment accuracy and patient care.

Challenges Ahead

While the stock's rise is encouraging, Profound Medical must navigate the complexities of hospital adoption. The pace at which healthcare providers integrate these innovative solutions will be critical in determining the company's long-term success. Investors should remain cautious and monitor adoption rates closely.

Looking Forward

As the demand for AI-driven healthcare solutions grows, Profound Medical is well-positioned to capitalize on this trend. However, the company must continue to demonstrate the effectiveness and reliability of its technologies to ensure sustained investor confidence and market growth. For more insights, check out our detailed analysis on Profound Medical Corp.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 29, 2026
Last Updated: September 29, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement